FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037955646> ?p ?o ?g. }

• W3037955646 endingPage "76" @default.
• W3037955646 startingPage "69" @default.
• W3037955646 abstract "to study the clinical, morphological and microcirculatory criteria for treatment efficiency and prognosis of local recurrence after HIFU.On the basis of the urological department of Clinical Hospital Russian Railways - Medicine in Barnaul (the clinical base of the Department of Urology and Andrology with a course of Specialized Surgery of FGBOU VO Altai State Medical University) for the period 2011-2018, a comprehensive examination and treatment of 240 patients with prostate cancer (PCa) by means of HIFU using Ablatherm was performed following transurethral resection of the prostate (TURP). The indication for HIFU was morphologically-proven PCa (stage T2a-cN0M0) in patients with contraindications due to comorbidities or those who refused from radical prostatectomy.A decrease in PSA to 0.5 ng/ml or less was observed in 74% of patients. A stable PSA level for 3 years was observed in 76% of patients. PSA levels differed depending on the PCa risk group. In the low-risk PCa, negative biopsy was seen in 89.6% of cases, in comparison with 72.2% and 69.4% in intermediate and high-risk PCa, respectively. There was a significant decrease in the volume of the prostate in all patients with low-risk PCa. The largest decrease in prostate volume was observed 12 months after HIFU. Regarding recurrence-free survival after HIFU therapy, during follow-up of 3 years or more, 77% of patients didnt have any signs of recurrence. A 3-year overall survival after HIFU was 83%. In addition, an increase in postoperative PSA levels, change in parameters of Doppler study and laser Doppler flowmetry at the area of the prostate during the period of 6-36 months after HIFU was associated with a significant increase in the risk of recurrence of PCa at biopsy.HIFU therapy is an effective treatment method for inducing prostate necrosis with minimal collateral damage to the surrounding tissue. The best results were achieved in patients with low-risk PCa. There were minimal adverse events after HIFU. In addition, in case of relapse after HIFU therapy, there is an opportunity for an early assessment of the efficiency and prognosis." @default.
• W3037955646 created "2020-07-02" @default.
• W3037955646 creator A5012395702 @default.
• W3037955646 creator A5038206625 @default.
• W3037955646 creator A5073327810 @default.
• W3037955646 creator A5075579231 @default.
• W3037955646 date "2020-06-29" @default.
• W3037955646 modified "2023-10-16" @default.
• W3037955646 title "Clinical, morphological and microcirculatory criteria of local recurrence of the prostate cancer after HIFU therapy" @default.
• W3037955646 doi "https://doi.org/10.18565/urology.2020.3.69-76" @default.
• W3037955646 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32597589" @default.
• W3037955646 hasPublicationYear "2020" @default.
• W3037955646 type Work @default.
• W3037955646 sameAs 3037955646 @default.
• W3037955646 citedByCount "1" @default.
• W3037955646 countsByYear W30379556462022 @default.
• W3037955646 crossrefType "journal-article" @default.
• W3037955646 hasAuthorship W3037955646A5012395702 @default.
• W3037955646 hasAuthorship W3037955646A5038206625 @default.
• W3037955646 hasAuthorship W3037955646A5073327810 @default.
• W3037955646 hasAuthorship W3037955646A5075579231 @default.
• W3037955646 hasConcept C121608353 @default.
• W3037955646 hasConcept C126322002 @default.
• W3037955646 hasConcept C126894567 @default.
• W3037955646 hasConcept C141071460 @default.
• W3037955646 hasConcept C2775934546 @default.
• W3037955646 hasConcept C2776235491 @default.
• W3037955646 hasConcept C2777008409 @default.
• W3037955646 hasConcept C2779466945 @default.
• W3037955646 hasConcept C2780192828 @default.
• W3037955646 hasConcept C2780768273 @default.
• W3037955646 hasConcept C71924100 @default.
• W3037955646 hasConceptScore W3037955646C121608353 @default.
• W3037955646 hasConceptScore W3037955646C126322002 @default.
• W3037955646 hasConceptScore W3037955646C126894567 @default.
• W3037955646 hasConceptScore W3037955646C141071460 @default.
• W3037955646 hasConceptScore W3037955646C2775934546 @default.
• W3037955646 hasConceptScore W3037955646C2776235491 @default.
• W3037955646 hasConceptScore W3037955646C2777008409 @default.
• W3037955646 hasConceptScore W3037955646C2779466945 @default.
• W3037955646 hasConceptScore W3037955646C2780192828 @default.
• W3037955646 hasConceptScore W3037955646C2780768273 @default.
• W3037955646 hasConceptScore W3037955646C71924100 @default.
• W3037955646 hasLocation W30379556461 @default.
• W3037955646 hasLocation W30379556462 @default.
• W3037955646 hasOpenAccess W3037955646 @default.
• W3037955646 hasPrimaryLocation W30379556461 @default.
• W3037955646 hasRelatedWork W1530684645 @default.
• W3037955646 hasRelatedWork W1627654306 @default.
• W3037955646 hasRelatedWork W1979955543 @default.
• W3037955646 hasRelatedWork W2060445317 @default.
• W3037955646 hasRelatedWork W2068509057 @default.
• W3037955646 hasRelatedWork W2078797104 @default.
• W3037955646 hasRelatedWork W2111952090 @default.
• W3037955646 hasRelatedWork W2116884624 @default.
• W3037955646 hasRelatedWork W2559494340 @default.
• W3037955646 hasRelatedWork W2941990228 @default.
• W3037955646 hasVolume "3_2020" @default.
• W3037955646 isParatext "false" @default.
• W3037955646 isRetracted "false" @default.
• W3037955646 magId "3037955646" @default.
• W3037955646 workType "article" @default.